Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/8168091

Cancer Res. 1994 May 15 54 10 2636-42

Download in:

View as

Triples

General Info

PMID
8168091